Stellant Securities Receives BSE Approval for Preferential Issue at Rs 602

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Stellant Securities Receives BSE Approval for Preferential Issue at Rs 602

Stellant Securities (India) Ltd has received BSE in-principle approval for a preferential issue of 1,289,177 equity shares to non-promoters and 348,837 warrants to promoters at a minimum price of Rs 602 per unit.

Stellant Securities Gets BSE Nod for Rs 602 Preferential Issue

1,289,177 equity shares to be issued to non-promoters and 348,837 warrants to promoters.
Minimum issue price set at Rs 602 per unit for both shares and warrants.

Reader Takeaway: Regulatory approval clears path for capital infusion, though strict trading restrictions on allottees remain mandatory.

What just happened

Stellant Securities (India) Ltd has received formal in-principle approval from the BSE, dated October 21, 2026, for its planned preferential issue. The approval allows the company to issue equity shares to non-promoters and convertible warrants to the promoter group. The issue price is fixed at a minimum of Rs 602 per unit.

Why this matters

This approval is a critical procedural milestone in the company’s capital-raising exercise. The infusion of funds through this preferential route will support the company's financial planning. The exchange has mandated strict compliance, including specific undertakings from allottees regarding trading activities.

Regulatory Requirements

The BSE has placed the responsibility of monitoring compliance squarely on Stellant Securities. Key requirements include:

  • Ensuring all activities align with the Companies Act and SEBI regulations.
  • Obtaining mandatory undertakings from allottees to prohibit intra-day trading or selling shares prior to the allotment date.
  • The exchange holds the right to withdraw the approval if any discrepancies or non-compliance issues are found.

What to track next

Investors should look for the formal allotment announcement and updates regarding the conversion timeline for the warrants. Additionally, watch for any further disclosures regarding the utilization of these funds and the official listing of the new shares.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.